MRSN: Mersana Therapeutics, Inc. Stock

by  •  • Comments Off on MRSN: Mersana Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 42.84
Enterprise Value ($M) -39.05
Book Value ($M) -30.87
Book Value / Share -0.25
Price / Book -1.39
NCAV ($M) -37.15
NCAV / Share -0.30
Price / NCAV -1.15

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.37
Return on Equity (ROE) -2.64

Liquidity (mrq)
Quick Ratio 1.83
Current Ratio 1.83

Balance Sheet (mrq) ($M)
Current Assets 106.19
Assets 112.47
Liabilities 143.34
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 40.50
Operating Income -73.34
Net Income -69.19
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -82.34
Cash from Investing 11.44
Cash from Financing 4.09

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-15 13G/A EcoR1 Capital, LLC 0.00 -100.00
05-15 13G/A Venrock Healthcare Capital Partners III, L.P. 2.90 -65.16
05-15 13G Schonfeld Strategic Advisors LLC 6.11
04-30 13G/A Vanguard Group Inc 6.72 34.31
04-17 13G/A BlackRock, Inc. 6.70 -9.57
12-26 13G/A Nextech Crossover I GP S.a r.l. 10.40 0.00
11-15 13D/A Bain Capital Life Sciences Fund II, L.P. 4.00 22.92
11-14 13G/A Balyasny Asset Management Llc 0.44 -94.48
10-15 13G/A Silverarc Capital Management, Llc 1.43 -72.68

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-03 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-30 425,167 1,372,632 30.97
2025-05-29 801,892 2,081,164 38.53
2025-05-28 659,756 2,271,015 29.05
2025-05-27 763,095 2,244,915 33.99

(click for more detail)

Similar Companies
MLYS – Mineralys Therapeutics, Inc. MNMD – Mind Medicine (MindMed) Inc.
MRNA – Moderna, Inc. MRVI – Maravai LifeSciences Holdings, Inc.
MYGN – Myriad Genetics, Inc.


Financial data and stock pages provided by
Fintel.io